Your account is not claimed yet. You can sign up with ORCID to claim your account.

Rajaventhan Srirajaskanthan (Raj Srirajaskanthan, R Srirajaskanthan)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Journal of neuroendocrinology

Endocrine oncology (Bristol, England)

Current oncology reports

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Joel George, John K Ramage, Benjamin White, Rajaventhan Srirajaskanthan
The role of serotonin inhibition within the treatment of carcinoid syndrome. Endocrine oncology (Bristol, England) 3 (1) (2023)
Sangeeta A Paisey, Scott Weerasuriya, Kieran Palmer, Benjamin Easton White, Rajaventhan Srirajaskanthan, Kandiah Chandrakumaran, John K Ramage
Primary renal neuroendocrine neoplasms: A systematic literature review, report of four local cases, and original survival analysis of 63 patients from a national registry 2012-2018. Journal of neuroendocrinology (2022)
Dominique S V M Clement, Shaunak Navalkissoor, Rajaventhan Srirajaskanthan, Frédéric Courbon, Lawrence O Dierickx, Amy Eccles, Valerie Lewington, Mercedes Mitjavila, Juan Carlos Percovich, Benoît Lequoy, Beilei He, Ilya Folitar, John K Ramage
Efficacy and safety of 177 Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study. European journal of nuclear medicine and molecular imaging 49 (10) (2022)
Sangeeta A Paisey, Scott Weerasuriya, Kieran Palmer, Benjamin Easton White, Rajaventhan Srirajaskanthan, Kandiah Chandrakumaran, John K Ramage
Primary renal neuroendocrine neoplasms: A systematic literature review, report of four local cases, and original survival analysis of 63 patients from a national registry 2012-2018. Journal of neuroendocrinology 34 (12) (2022)
Sangeeta A Paisey, Scott Weerasuriya, Kieran Palmer, Benjamin Easton White, Rajaventhan Srirajaskanthan, Kandiah Chandrakumaran, John K Ramage
Primary renal neuroendocrine neoplasms: A systematic literature review, report of four local cases, and original survival analysis of 63 patients from a national registry 2012-2018. Journal of neuroendocrinology 34 (12) (2022)
Jack Cope, Rajaventhan Srirajaskanthan
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation? Current oncology reports 24 (3) (2022)
Sangeeta A Paisey, Scott Weerasuriya, Kieran Palmer, Benjamin Easton White, Rajaventhan Srirajaskanthan, Kandiah Chandrakumaran, John K Ramage
Primary renal neuroendocrine neoplasms: A systematic literature review, report of four local cases, and original survival analysis of 63 patients from a national registry 2012-2018. Journal of neuroendocrinology 34 (12) (2022)
David C Llewellyn, Rajaventhan Srirajaskanthan, Royce P Vincent, Catherine Guy, Eftychia E Drakou, Simon J B Aylwin, Ashley B Grossman, John K Ramage, Georgios K Dimitriadis
Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis. Endocrine connections 10 (4) (2021)
Dominique Clement, John Ramage, Rajaventhan Srirajaskanthan
Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome. Journal of oncology 2020 (2020)
Shweta Hota, Rajaventhan Srirajaskanthan
Regarding "TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World". The oncologist 25 (7) (2020)
Rajaventhan Srirajaskanthan
Advances in Endoscopic Techniques for Resection of Duodenal Neuroendocrine Tumours. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 23 (6) (2019)
Ron Basuroy, Catherine Bouvier, John Keith Ramage, Maia Sissons, Rajaventhan Srirajaskanthan
Delays and routes to diagnosis of neuroendocrine tumours. BMC cancer 18 (1) (2018)

Rajaventhan Srirajaskanthan.css-eqlu8i{font-size:small;padding-left:4px;} (Raj Srirajaskanthan, R Srirajaskanthan)

Publication Activity (10 Years)

Top Topics

Top Venues

Rajaventhan Srirajaskanthan (Raj Srirajaskanthan, R Srirajaskanthan)